In line with previous reports [20, 21, 29], astrocytes treated with Aβ42 appeared to enhance expression of BACE1 (Fig. 4C), suggesting that elevated BACE1 in AD brains might have vicious inhibitory effect on astrocytic Aβ clearance. The gene discussed is BACE1; the disease is Alzheimer disease.